In its fourth consecutive year, the Women and HIV Think Tank officially changed its name to the "Women's Research Initiative on HIV/AIDS (WRI)" in 2005 to accurately reflect the real work of this group, to convey our ongoing commitment to tangible and measurable results in the management of HIV disease in women, and to establish TWP's role in providing sustained leadership for this effort. The most significant outcome of the 2005 meeting is the unequivocal consensus that emerged that increasing the participation of women in research is the most tangible mechanism for improving HIV treatment and prevention efforts for all women over the long term. Participants elected to form three working groups to pursue initiatives in 2006:
- Standards of Treatment and Care
- Policy Agenda
- Community Engagement
The 2005 Think Tank included thirty of the nearly sixty individuals involved in this initiative. Following our multidisciplinary focus, the participants represented research institutions, clinics, government agencies, advocacy organizations, and pharmaceutical companies. A list of the 2005 meeting participants can be found below.
For the full 2005 meeting report and a detailed action plan of the working groups, please click below.
2005 WRI Meeting Participants
| Judith D. Auerbach, PhD Vice President, Public Policy and Program Development amfAR |
Dawn Averitt Bridge Founder The Well Project |
| Gina Brown, MD Medical Director Cicatelli Associates, Inc. |
Susan Ellen Cohn, MD, MPH Associate Professor of Medicine University of Rochester |
| Jenna Conley Senior Manager Gilead Sciences |
Robert W. Coombs, MD, PhD, FRCPC Professor, Laboratory Medicine University of Washington |
| Terri Creagh, PhD Clinical and Epidemiologic Research |
Ron Falcon, MD Medical Director, Virology Tibotec Therapeutics |
| Judith Feinberg, MD Professor of Medicine University of Cincinnati |
Becky Griesse Research Assistant Forum for Collaborative HIV Research |
| Jane Hitti, MD University of Washington Medical Center |
Beri Hull Global Advocacy Officer: Access to Care, Treatment and Support The International Community of Women Living with HIV and AIDS (ICW) |
| Ben Kozub Product Manager, HIV Boehringer Ingelheim Pharmaceuticals |
Sharon Lee, MD Director Family Health Center |
| Heidi Nass Coordinator, Treatment Support and Education Program HIV Care Program, University of Wisconsin Hospital and Clinics |
Nancy Norman, MD, MPH Medical Director Boston Public Health Commission |
| Cathy Olufs Education Director CorrectHELP - The Corrections HIV Education and Law Project |
Nancy Padian, PhD Professor UCSF |
| Andrew Pavia, MD University of Utah |
Kristy D. Porter, PharmD Associate Director, Virology Medical Affairs Bristol-Myers Squibb |
| Tonia Poteat, PA-C Grady Infectious Disease Program |
Patricia Reichelderfer, PhD Microbiologist NIH/NICHD |
| Star Seyedkazemi, PharmD Clinical Science Manager, Abbott Virology Abbott Laboratories |
Kathleen E. Squires, MD Director, Division of Infectious Diseases Thomas Jefferson University |
| Stephen Storfer, MD Associate Director, Virology Clinical and Scientific Affairs Boehringer Ingelheim Pharmaceuticals, Inc. |
Melanie Thompson, MD Principal Investigator AIDS Research Consortium of Atlanta |
| Fulvia Veronese, PhD Health Science Administrator NIH, Office of AIDS Research Etiology and Pathogenesis and Microbicide Section |
Meeting Staff
Megan Raspa
Project Manager
The Well Project
Facilitators
Richard Averitt
Chief Operating Officer
The Well Project
Ron Wilder
President
Aligned Action, Inc.
Meeting Planners
Debbie Cooke
VP, Chief Operations Officer
Meeting Masters, Inc.
Tina DeRenzis
President
Meeting Masters, Inc.
